Erudio Healtherudio.com
Sponsor
ADC Therapeutics trials: what clinicians said in public
No HCP commentary report on a trial sponsored by ADC Therapeutics yet. Erudio has found public clinician commentary on 4 clinical trials sponsored by ADC Therapeutics: LOTIS-2, LOTIS-5, LOTIS-7 and LOTIS-9. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (ADC Therapeutics S.A.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| LOTIS-2 NCT03589469 · ADC Therapeutics S.A. DeepView → | relapsed or refractory diffuse large B-cell lymphoma | Phase 2 | Deep | View | |||
| LOTIS-7 NCT04970901 · ADC Therapeutics S.A. DeepView → | relapsed or refractory B-cell non-Hodgkin lymphoma | Phase 1 | Deep | View | |||
| LOTIS-5 NCT04384484 · ADC Therapeutics S.A. StandardView → | relapsed or refractory diffuse large B-cell lymphoma | Phase 3 | Standard | View | |||
| LOTIS-9 NCT05144009 · ADC Therapeutics S.A. FocusedView → | previously untreated unfit/frail diffuse large B-cell lymphoma | Phase 2 | Focused | View | |||